- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatotoxicity mechanisms of isoniazid: A mini-review
Authors
Keywords
-
Journal
JOURNAL OF APPLIED TOXICOLOGY
Volume 35, Issue 12, Pages 1427-1432
Publisher
Wiley
Online
2015-06-19
DOI
10.1002/jat.3175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of CYP2E1 in testes of isoniazid-treated rats as possible cause of testicular disorders
- (2015) Ganna M. Shayakhmetova et al. TOXICOLOGY LETTERS
- Hepatotoxicity from antituberculous therapy in the elderly: A systematic review
- (2015) Jennifer D. Hosford et al. TUBERCULOSIS
- Berberine Attenuates Isoniazid-Induced Hepatotoxicity by Modulating Peroxisome Proliferator-Activated Receptor ?, Oxidative Stress and Inflammation
- (2014) Ayman M. Mahmoud et al. International Journal of Pharmacology
- Lipopolysaccharide exposure augments isoniazide-induced liver injury
- (2014) Yijing Su et al. JOURNAL OF APPLIED TOXICOLOGY
- Mechanisms of isoniazid-induced idiosyncratic liver injury: Emerging role of mitochondrial stress
- (2014) Urs A Boelsterli et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
- (2014) Neha Singla et al. TUBERCULOSIS
- Bypassing the compromised mitochondrial electron transport with methylene blue alleviates efavirenz/isoniazid-induced oxidant stress and mitochondria-mediated cell death in mouse hepatocytes
- (2014) Kang Kwang Lee et al. Redox Biology
- A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide
- (2013) Tung-Yuan Shih et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of CYP3A in Isoniazid Metabolism In Vivo
- (2013) Ke Liu et al. Drug Metabolism and Pharmacokinetics
- Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage
- (2013) Amita Jaswal et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- In vitro toxic action potential of anti tuberculosis drugs and their combinations
- (2013) Riffat Fatima et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): A critical discussion
- (2013) Deepa K. Ingawale et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes
- (2013) Kang Kwang Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure
- (2013) Imir G. Metushi et al. HEPATOLOGY
- Isoniazid hepatotoxicity: Progress in understanding the immunologic component
- (2013) Laura James et al. HEPATOLOGY
- N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients
- (2013) N. P. C. Santos et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Isoniazid-induced liver injury and immune response in mice
- (2013) Imir G. Metushi et al. Journal of Immunotoxicology
- Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin
- (2013) Imir G. Metushi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy
- (2013) Feng Li et al. NATURE MEDICINE
- Hepatocyte Growth Factor Protects Against Isoniazid/Rifampicin-Induced Oxidative Liver Damage
- (2013) Cristina Enriquez-Cortina et al. TOXICOLOGICAL SCIENCES
- Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes
- (2013) Yanyan Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- PXR-ALAS1: A key regulatory pathway in liver toxicity induced by isoniazid-rifampicin antituberculosis treatment
- (2013) Said Lyoumi et al. Clinics and Research in Hepatology and Gastroenterology
- Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats
- (2012) Imir G. Metushi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid
- (2012) Jie Cheng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Genetic variants in antioxidant pathway: Risk factors for hepatotoxicity in tuberculosis patients
- (2012) Kazutaka Nanashima et al. TUBERCULOSIS
- Cellular toxicity of isoniazid together with rifampicin and the metabolites of isoniazid on QSG-7701 hepatocytes
- (2012) Zhi-Hua Zhang et al. Asian Pacific Journal of Tropical Medicine
- Hepatoprotective potential of ethanolic extract of Ziziphus oenoplia (L.) Mill roots against antitubercular drugs induced hepatotoxicity in experimental models
- (2012) Ch V Rao et al. Asian Pacific Journal of Tropical Medicine
- A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity
- (2011) I G Metushi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice
- (2011) Xi Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role
- (2011) J. Aubert et al. Clinics and Research in Hepatology and Gastroenterology
- Role of oxidative stress and nitric oxide in the protective effects of α-lipoic acid and aminoguanidine against isoniazid–rifampicin-induced hepatotoxicity in rats
- (2010) Evan I. Saad et al. FOOD AND CHEMICAL TOXICOLOGY
- Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis
- (2010) Wan Beom Park et al. JOURNAL OF INFECTION
- Studies on toxicity of antitubercular drugs namely isoniazid, rifampicin, and pyrazinamide in an in vitro model of HepG2 cell line
- (2010) Meenakshi Singh et al. MEDICINAL CHEMISTRY RESEARCH
- Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity
- (2010) Patrick J. Shaw et al. TOXICOLOGICAL SCIENCES
- Isoniazid-induced apoptosis in HepG2 cells: Generation of oxidative stress and Bcl-2 down-regulation
- (2010) Smrati Bhadauria et al. TOXICOLOGY MECHANISMS AND METHODS
- Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?
- (2009) Jiang Yue et al. BRITISH JOURNAL OF PHARMACOLOGY
- d-Penicillamine-Induced Autoimmunity: Relationship to Macrophage Activation
- (2009) Jinze Li et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Immunoallergic Drug-Induced Liver Injury in Humans
- (2009) Jack Uetrecht SEMINARS IN LIVER DISEASE
- Protective effects of thiopronin against isoniazid-induced hepatotoxicity in rats
- (2009) Jiang Yue et al. TOXICOLOGY
- Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity
- (2009) Yukitaka Yoshikawa et al. TOXICOLOGY IN VITRO
- Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity
- (2008) Alma Tostmann et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats
- (2008) Jiang Yue et al. PHARMACOLOGICAL RESEARCH
- Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model
- (2008) Shahrzad Tafazoli et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Oxidative stress potentiated by diallylsulfide, a selective CYP2E1 inhibitor, in isoniazid toxic effect on rat primary hepatocytes
- (2008) Q ZHAI et al. TOXICOLOGY LETTERS
- Isoniazid
- (2008) TUBERCULOSIS
- Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures
- (2007) C Shen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Isoniazid-rifampicin induced lipid changes in rats
- (2007) R. Pal et al. CLINICA CHIMICA ACTA
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search